| Symbol |
Name |
Standardized Value |
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
3.689
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
3.576
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
3.575
|
|
TAC1
|
tachykinin, precursor 1
|
3.428
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
3.385
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
3.358
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
3.222
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
3.206
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
3.193
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
3.144
|
|
CALCRL
|
calcitonin receptor-like
|
3.082
|
|
CALCB
|
calcitonin-related polypeptide beta
|
3.08
|
|
NOTCH3
|
notch 3
|
3.064
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
3.048
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
3.001
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
2.908
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
2.812
|
|
VIP
|
vasoactive intestinal peptide
|
2.779
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
2.733
|
|
IL1B
|
interleukin 1, beta
|
2.702
|
|
BDNF
|
brain-derived neurotrophic factor
|
2.697
|
|
IL6
|
interleukin 6
|
2.687
|
|
MAOA
|
monoamine oxidase A
|
2.674
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
2.669
|
|
TNF
|
tumor necrosis factor
|
2.659
|
|
PHACTR1
|
phosphatase and actin regulator 1
|
2.653
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
2.639
|
|
KNG1
|
kininogen 1
|
2.634
|
|
HTR1F
|
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
|
2.632
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
2.631
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
2.613
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
2.604
|
|
KRT76
|
keratin 76, type II
|
2.591
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
2.587
|
|
TACR1
|
tachykinin receptor 1
|
2.578
|
|
ACE
|
angiotensin I converting enzyme
|
2.549
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
2.548
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
2.542
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
2.54
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
2.54
|
|
MAOB
|
monoamine oxidase B
|
2.535
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
2.534
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
2.512
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
2.508
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.497
|
|
OPRM1
|
opioid receptor, mu 1
|
2.478
|
|
ADM
|
adrenomedullin
|
2.475
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
2.474
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
2.473
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
2.473
|
|
POMC
|
proopiomelanocortin
|
2.469
|
|
ANK1
|
ankyrin 1, erythrocytic
|
2.458
|
|
KCNK10
|
potassium channel, two pore domain subfamily K, member 10
|
2.457
|
|
INS
|
insulin
|
2.457
|
|
NPY
|
neuropeptide Y
|
2.455
|
|
IAPP
|
islet amyloid polypeptide
|
2.445
|
|
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3
|
2.44
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
2.435
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
2.432
|
|
EDN1
|
endothelin 1
|
2.397
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
2.394
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
2.393
|
|
OPN4
|
opsin 4
|
2.383
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
2.379
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
2.377
|
|
COMT
|
catechol-O-methyltransferase
|
2.367
|
|
PANX1
|
pannexin 1
|
2.354
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
2.349
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
2.347
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
2.342
|
|
TSPAN2
|
tetraspanin 2
|
2.328
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
2.326
|
|
ALB
|
albumin
|
2.326
|
|
IL10
|
interleukin 10
|
2.301
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
2.299
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
2.297
|
|
DRD2
|
dopamine receptor D2
|
2.291
|
|
POLG
|
polymerase (DNA directed), gamma
|
2.275
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
2.261
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
2.254
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
2.248
|
|
ADM2
|
adrenomedullin 2
|
2.244
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
2.238
|
|
PDYN
|
prodynorphin
|
2.236
|
|
FAAH
|
fatty acid amide hydrolase
|
2.234
|
|
CRH
|
corticotropin releasing hormone
|
2.23
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
2.227
|
|
ANKDD1B
|
ankyrin repeat and death domain containing 1B
|
2.225
|
|
PLAT
|
plasminogen activator, tissue
|
2.222
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
2.222
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
2.219
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
2.215
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
2.21
|
|
CALCR
|
calcitonin receptor
|
2.208
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
2.207
|
|
PRL
|
prolactin
|
2.198
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
2.196
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
2.187
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
2.185
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
2.182
|
|
LAPTM4A
|
lysosomal protein transmembrane 4 alpha
|
2.18
|
|
KCNK5
|
potassium channel, two pore domain subfamily K, member 5
|
2.179
|
|
LIPN
|
lipase, family member N
|
2.176
|
|
ASTN2
|
astrotactin 2
|
2.175
|
|
IL1A
|
interleukin 1, alpha
|
2.168
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
2.168
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
2.168
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
2.165
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
2.154
|
|
COL4A1
|
collagen, type IV, alpha 1
|
2.154
|
|
KCNK4
|
potassium channel, two pore domain subfamily K, member 4
|
2.149
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
2.142
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
2.138
|
|
LEP
|
leptin
|
2.132
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
2.131
|
|
PRDM16
|
PR domain containing 16
|
2.131
|
|
CREB1
|
cAMP responsive element binding protein 1
|
2.13
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
2.124
|
|
REN
|
renin
|
2.12
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
2.112
|
|
F2
|
coagulation factor II (thrombin)
|
2.11
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
2.105
|
|
CAV2
|
caveolin 2
|
2.104
|
|
PNOC
|
prepronociceptin
|
2.1
|
|
SCT
|
secretin
|
2.098
|
|
ESR1
|
estrogen receptor 1
|
2.098
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
2.098
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
2.092
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
2.087
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
2.085
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
2.08
|
|
ARRB2
|
arrestin, beta 2
|
2.079
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
2.071
|
|
IFNG
|
interferon, gamma
|
2.068
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
2.068
|
|
APOE
|
apolipoprotein E
|
2.063
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
2.063
|
|
FMR1
|
fragile X mental retardation 1
|
2.062
|
|
S100B
|
S100 calcium binding protein B
|
2.062
|
|
HTR1E
|
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled
|
2.058
|
|
APP
|
amyloid beta (A4) precursor protein
|
2.055
|
|
GCG
|
glucagon
|
2.055
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
2.051
|
|
TLR4
|
toll-like receptor 4
|
2.043
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
2.04
|
|
MMP9
|
matrix metallopeptidase 9
|
2.04
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
2.04
|
|
CPQ
|
carboxypeptidase Q
|
2.036
|
|
GFAP
|
glial fibrillary acidic protein
|
2.034
|
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit
|
2.025
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
2.021
|
|
HDAC9
|
histone deacetylase 9
|
2.019
|
|
CSNK1D
|
casein kinase 1, delta
|
2.017
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
2.016
|
|
CALML3
|
calmodulin-like 3
|
2.015
|
|
CALML6
|
calmodulin-like 6
|
2.013
|
|
CALML4
|
calmodulin-like 4
|
2.013
|
|
CALML5
|
calmodulin-like 5
|
2.01
|
|
AIF1
|
allograft inflammatory factor 1
|
2.009
|
|
SV2A
|
synaptic vesicle glycoprotein 2A
|
2.008
|
|
TGFB1
|
transforming growth factor, beta 1
|
2.008
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
2.007
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
2.007
|
|
SLC24A3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3
|
2.006
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
2.0
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
1.995
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
1.989
|
|
VWF
|
von Willebrand factor
|
1.988
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.986
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
1.984
|
|
ARRB1
|
arrestin, beta 1
|
1.983
|
|
CRCP
|
CGRP receptor component
|
1.982
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
1.981
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
1.98
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
1.978
|
|
SST
|
somatostatin
|
1.977
|
|
IL4
|
interleukin 4
|
1.976
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
1.974
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
1.973
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.973
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.968
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
1.966
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.966
|
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
|
1.964
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
1.961
|
|
HRH1
|
histamine receptor H1
|
1.96
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.959
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.958
|
|
MEF2D
|
myocyte enhancer factor 2D
|
1.954
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
1.952
|
|
TH
|
tyrosine hydroxylase
|
1.951
|
|
SUGCT
|
succinyl-CoA:glutarate-CoA transferase
|
1.95
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.949
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
1.948
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
1.948
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
1.944
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
1.94
|
|
MGLL
|
monoglyceride lipase
|
1.94
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
1.933
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
1.929
|
|
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit
|
1.929
|
|
TRIM32
|
tripartite motif containing 32
|
1.927
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
1.926
|
|
CD4
|
CD4 molecule
|
1.919
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
1.912
|
|
NAV1
|
neuron navigator 1
|
1.907
|
|
IL2
|
interleukin 2
|
1.9
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
1.9
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
1.896
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.894
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
1.894
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
1.889
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
1.888
|
|
HRH3
|
histamine receptor H3
|
1.882
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
1.881
|
|
FHL5
|
four and a half LIM domains 5
|
1.881
|
|
MTDH
|
metadherin
|
1.878
|
|
UFL1
|
UFM1-specific ligase 1
|
1.878
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1.87
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.868
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
1.866
|
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2
|
1.865
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1.865
|
|
IL17A
|
interleukin 17A
|
1.864
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
1.861
|
|
KCNK1
|
potassium channel, two pore domain subfamily K, member 1
|
1.855
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.852
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.849
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
1.848
|
|
CAV3
|
caveolin 3
|
1.846
|
|
GAL
|
galanin/GMAP prepropeptide
|
1.846
|
|
TAAR1
|
trace amine associated receptor 1
|
1.845
|
|
GABRQ
|
gamma-aminobutyric acid (GABA) A receptor, theta
|
1.845
|
|
JUN
|
jun proto-oncogene
|
1.845
|
|
OXTR
|
oxytocin receptor
|
1.844
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.842
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.842
|
|
CKB
|
creatine kinase, brain
|
1.84
|
|
EDNRA
|
endothelin receptor type A
|
1.839
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.834
|
|
CKM
|
creatine kinase, muscle
|
1.833
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.832
|
|
RHO
|
rhodopsin
|
1.829
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.828
|
|
EGF
|
epidermal growth factor
|
1.826
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
1.825
|
|
NEFL
|
neurofilament, light polypeptide
|
1.824
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.823
|
|
IL18
|
interleukin 18
|
1.819
|
|
DRD4
|
dopamine receptor D4
|
1.817
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
1.816
|
|
TSPO
|
translocator protein (18kDa)
|
1.816
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
1.809
|
|
ACTB
|
actin, beta
|
1.806
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.805
|
|
PXDN
|
peroxidasin
|
1.805
|
|
PXDNL
|
peroxidasin-like
|
1.805
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
1.802
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1.797
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.796
|
|
VWA8
|
von Willebrand factor A domain containing 8
|
1.788
|
|
BCHE
|
butyrylcholinesterase
|
1.785
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.781
|
|
KCNK17
|
potassium channel, two pore domain subfamily K, member 17
|
1.78
|
|
COL4A2
|
collagen, type IV, alpha 2
|
1.78
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.777
|
|
OPRD1
|
opioid receptor, delta 1
|
1.773
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
1.772
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
1.771
|
|
PENK
|
proenkephalin
|
1.77
|
|
ASIC4
|
acid sensing (proton gated) ion channel family member 4
|
1.769
|
|
TAC3
|
tachykinin 3
|
1.767
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
1.766
|
|
NTS
|
neurotensin
|
1.766
|
|
ADORA1
|
adenosine A1 receptor
|
1.765
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
1.765
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
1.764
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
1.764
|
|
MYORG
|
myogenesis regulating glycosidase (putative)
|
1.763
|
|
DRD3
|
dopamine receptor D3
|
1.762
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
1.762
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
1.759
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.755
|
|
MPPED2
|
metallophosphoesterase domain containing 2
|
1.755
|
|
PVALB
|
parvalbumin
|
1.754
|
|
GPR55
|
G protein-coupled receptor 55
|
1.754
|
|
CCK
|
cholecystokinin
|
1.754
|
|
MAPT
|
microtubule-associated protein tau
|
1.752
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
1.749
|
|
SYT1
|
synaptotagmin I
|
1.748
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.748
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.745
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
1.745
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.743
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.74
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.74
|
|
ADORA2A
|
adenosine A2a receptor
|
1.739
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
1.734
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
1.73
|
|
KCNK12
|
potassium channel, two pore domain subfamily K, member 12
|
1.726
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.724
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
1.724
|
|
TPM3
|
tropomyosin 3
|
1.724
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
1.723
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
1.722
|
|
CYCS
|
cytochrome c, somatic
|
1.722
|
|
SH2D5
|
SH2 domain containing 5
|
1.72
|
|
CD8A
|
CD8a molecule
|
1.718
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
1.717
|
|
PTH
|
parathyroid hormone
|
1.715
|
|
STX1A
|
syntaxin 1A (brain)
|
1.715
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
1.714
|
|
RNF213
|
ring finger protein 213
|
1.713
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.706
|
|
STXBP1
|
syntaxin binding protein 1
|
1.704
|
|
COQ8A
|
coenzyme Q8A
|
1.704
|
|
ADRB1
|
adrenoceptor beta 1
|
1.702
|
|
AOC1
|
amine oxidase, copper containing 1
|
1.701
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.7
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.699
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
1.696
|
|
GPX3
|
glutathione peroxidase 3
|
1.694
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
1.692
|
|
EDNRB
|
endothelin receptor type B
|
1.689
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.688
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
1.688
|
|
AVP
|
arginine vasopressin
|
1.687
|
|
PRKCG
|
protein kinase C, gamma
|
1.687
|
|
GPX7
|
glutathione peroxidase 7
|
1.683
|
|
GPX6
|
glutathione peroxidase 6
|
1.683
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
1.679
|
|
GPX5
|
glutathione peroxidase 5
|
1.679
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
1.678
|
|
TACR3
|
tachykinin receptor 3
|
1.678
|
|
GPX2
|
glutathione peroxidase 2
|
1.676
|
|
TACR2
|
tachykinin receptor 2
|
1.673
|
|
ATP1A4
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide
|
1.669
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
1.668
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
1.665
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
1.664
|
|
TWNK
|
twinkle mtDNA helicase
|
1.663
|
|
TPH1
|
tryptophan hydroxylase 1
|
1.662
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.662
|
|
OSTF1
|
osteoclast stimulating factor 1
|
1.661
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
1.659
|
|
HMGB1
|
high mobility group box 1
|
1.658
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
1.657
|
|
GPR35
|
G protein-coupled receptor 35
|
1.657
|
|
CA2
|
carbonic anhydrase II
|
1.656
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
1.655
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
1.654
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
1.652
|
|
FAM136A
|
family with sequence similarity 136, member A
|
1.651
|
|
IL13
|
interleukin 13
|
1.645
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
1.644
|
|
PLG
|
plasminogen
|
1.643
|
|
MBP
|
myelin basic protein
|
1.641
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
1.64
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
1.64
|
|
VAMP2
|
vesicle-associated membrane protein 2 (synaptobrevin 2)
|
1.638
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
1.636
|
|
HMOX1
|
heme oxygenase 1
|
1.635
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.634
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
1.631
|
|
ARTN
|
artemin
|
1.627
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
1.627
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
1.625
|
|
ZCCHC14
|
zinc finger, CCHC domain containing 14
|
1.625
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
1.625
|
|
KCNG4
|
potassium channel, voltage gated modifier subfamily G, member 4
|
1.625
|
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13
|
1.624
|
|
DAGLA
|
diacylglycerol lipase, alpha
|
1.622
|
|
OCLN
|
occludin
|
1.621
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
1.619
|
|
KCNK13
|
potassium channel, two pore domain subfamily K, member 13
|
1.618
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
1.618
|
|
NF1
|
neurofibromin 1
|
1.617
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
1.617
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
1.615
|
|
IL5
|
interleukin 5
|
1.613
|
|
DRD1
|
dopamine receptor D1
|
1.609
|
|
EHF
|
ets homologous factor
|
1.607
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
1.606
|
|
HRH2
|
histamine receptor H2
|
1.605
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
1.604
|
|
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)
|
1.602
|
|
SIRT1
|
sirtuin 1
|
1.599
|
|
KCNB2
|
potassium channel, voltage gated Shab related subfamily B, member 2
|
1.595
|
|
TP53
|
tumor protein p53
|
1.593
|
|
KARS1
|
lysyl-tRNA synthetase 1
|
1.591
|
|
NTF3
|
neurotrophin 3
|
1.59
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.59
|
|
AADAT
|
aminoadipate aminotransferase
|
1.589
|
|
FGF14
|
fibroblast growth factor 14
|
1.589
|
|
GRM4
|
glutamate receptor, metabotropic 4
|
1.588
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
1.584
|
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5
|
1.583
|
|
LTA
|
lymphotoxin alpha
|
1.581
|
|
NOTCH2NLC
|
notch 2 N-terminal like C
|
1.58
|
|
CHAT
|
choline O-acetyltransferase
|
1.579
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
1.579
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
1.576
|
|
SLC35A2
|
solute carrier family 35 (UDP-galactose transporter), member A2
|
1.576
|
|
GRIK4
|
glutamate receptor, ionotropic, kainate 4
|
1.574
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
1.573
|
|
TLR2
|
toll-like receptor 2
|
1.573
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
1.572
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
1.571
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
1.569
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.569
|
|
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1
|
1.568
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.566
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
1.566
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
1.566
|
|
OTOL1
|
otolin 1
|
1.564
|
|
KCNK16
|
potassium channel, two pore domain subfamily K, member 16
|
1.563
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
1.562
|
|
ITPK1
|
inositol-tetrakisphosphate 1-kinase
|
1.562
|
|
EGFR
|
epidermal growth factor receptor
|
1.561
|
|
PGR
|
progesterone receptor
|
1.56
|
|
PSEN1
|
presenilin 1
|
1.559
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.558
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
1.557
|
|
PMCH
|
pro-melanin-concentrating hormone
|
1.556
|
|
CLDN5
|
claudin 5
|
1.553
|
|
GLUL
|
glutamate-ammonia ligase
|
1.552
|
|
SHBG
|
sex hormone-binding globulin
|
1.55
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.549
|
|
TPH2
|
tryptophan hydroxylase 2
|
1.549
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
1.549
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.548
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
1.546
|
|
SYN1
|
synapsin I
|
1.545
|
|
NOTCH2NLA
|
notch 2 N-terminal like A
|
1.545
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
1.544
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
1.543
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
1.542
|
|
CNTNAP2
|
contactin associated protein-like 2
|
1.542
|
|
AMY1B
|
amylase, alpha 1B (salivary)
|
1.542
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
1.541
|
|
TAAR2
|
trace amine associated receptor 2
|
1.54
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
1.54
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.539
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
1.538
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.536
|
|
OTOG
|
otogelin
|
1.535
|
|
PER2
|
period circadian clock 2
|
1.533
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
1.532
|
|
PF4
|
platelet factor 4
|
1.529
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.529
|
|
PTX3
|
pentraxin 3, long
|
1.529
|
|
MPO
|
myeloperoxidase
|
1.526
|
|
NES
|
nestin
|
1.524
|
|
CREM
|
cAMP responsive element modulator
|
1.523
|
|
CA1
|
carbonic anhydrase I
|
1.523
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.521
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
1.521
|
|
KCNC1
|
potassium channel, voltage gated Shaw related subfamily C, member 1
|
1.52
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.52
|
|
PLCE1
|
phospholipase C, epsilon 1
|
1.519
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.518
|
|
MRGPRD
|
MAS-related GPR, member D
|
1.517
|
|
JAK2
|
Janus kinase 2
|
1.517
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
1.517
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.515
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
1.514
|
|
BAX
|
BCL2-associated X protein
|
1.512
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
1.511
|
|
KYNU
|
kynureninase
|
1.508
|
|
ADAMTSL4
|
ADAMTS-like 4
|
1.508
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
1.507
|
|
MMP2
|
matrix metallopeptidase 2
|
1.506
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.506
|
|
OGN
|
osteoglycin
|
1.505
|
|
NAPEPLD
|
N-acyl phosphatidylethanolamine phospholipase D
|
1.504
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
1.502
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.502
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
1.501
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
1.501
|
|
AGTR1
|
angiotensin II receptor, type 1
|
1.5
|
|
TJP1
|
tight junction protein 1
|
1.498
|
|
GFRA3
|
GDNF family receptor alpha 3
|
1.498
|
|
HDAC1
|
histone deacetylase 1
|
1.497
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
1.496
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
1.496
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
1.495
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
1.494
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
1.492
|
|
ZNF234
|
zinc finger protein 234
|
1.491
|
|
HTRA1
|
HtrA serine peptidase 1
|
1.491
|
|
ANK2
|
ankyrin 2, neuronal
|
1.49
|
|
HRH4
|
histamine receptor H4
|
1.489
|
|
MECP2
|
methyl CpG binding protein 2
|
1.488
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
1.486
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.485
|
|
TDO2
|
tryptophan 2,3-dioxygenase
|
1.483
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
1.482
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
1.481
|
|
TBL1X
|
transducin (beta)-like 1X-linked
|
1.481
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
1.48
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
1.48
|
|
CNNM2
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
1.48
|
|
NRXN1
|
neurexin 1
|
1.479
|
|
HSPA4
|
heat shock 70kDa protein 4
|
1.479
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
1.478
|
|
DRD5
|
dopamine receptor D5
|
1.477
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.477
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
1.477
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
1.476
|
|
ALPK1
|
alpha-kinase 1
|
1.476
|
|
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2
|
1.473
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
1.473
|
|
EPO
|
erythropoietin
|
1.47
|
|
SCN7A
|
sodium channel, voltage gated, type VII alpha subunit
|
1.47
|
|
VAMP1
|
vesicle-associated membrane protein 1 (synaptobrevin 1)
|
1.469
|
|
FGF6
|
fibroblast growth factor 6
|
1.468
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.467
|
|
HNMT
|
histamine N-methyltransferase
|
1.464
|
|
AJAP1
|
adherens junctions associated protein 1
|
1.464
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
1.464
|
|
TAC4
|
tachykinin 4 (hemokinin)
|
1.462
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
1.462
|
|
APOB
|
apolipoprotein B
|
1.462
|
|
IFNA1
|
interferon, alpha 1
|
1.461
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
1.459
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
1.458
|
|
HP
|
haptoglobin
|
1.458
|
|
NTF4
|
neurotrophin 4
|
1.456
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.456
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
1.454
|
|
GSR
|
glutathione reductase
|
1.454
|
|
TAAR5
|
trace amine associated receptor 5
|
1.451
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
1.451
|
|
ESS2
|
ess-2 splicing factor homolog
|
1.451
|
|
ATF3
|
activating transcription factor 3
|
1.45
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
1.45
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
1.449
|
|
CDK5
|
cyclin-dependent kinase 5
|
1.448
|
|
CSN3
|
casein kappa
|
1.448
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
1.447
|
|
EPRS1
|
glutamyl-prolyl-tRNA synthetase 1
|
1.447
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
1.445
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
1.443
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.441
|
|
TRH
|
thyrotropin-releasing hormone
|
1.44
|
|
EARS2
|
glutamyl-tRNA synthetase 2, mitochondrial
|
1.44
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.44
|
|
NBEAL1
|
neurobeachin-like 1
|
1.439
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
1.438
|
|
SOD1
|
superoxide dismutase 1, soluble
|
1.436
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.434
|
|
SYP
|
synaptophysin
|
1.432
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.43
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.43
|
|
INSR
|
insulin receptor
|
1.428
|
|
ATXN7
|
ataxin 7
|
1.428
|
|
ATXN1
|
ataxin 1
|
1.427
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
1.426
|
|
TGM2
|
transglutaminase 2
|
1.426
|
|
PRDX2
|
peroxiredoxin 2
|
1.426
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.426
|
|
FN1
|
fibronectin 1
|
1.425
|
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1
|
1.424
|
|
RIC8B
|
RIC8 guanine nucleotide exchange factor B
|
1.424
|
|
OR2F2
|
olfactory receptor, family 2, subfamily F, member 2
|
1.423
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.422
|
|
TMEM151A
|
transmembrane protein 151A
|
1.42
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.418
|
|
CLOCK
|
clock circadian regulator
|
1.416
|
|
SV2C
|
synaptic vesicle glycoprotein 2C
|
1.415
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.413
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.41
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
1.41
|
|
CPZ
|
carboxypeptidase Z
|
1.407
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
1.406
|
|
MRGPRE
|
MAS-related GPR, member E
|
1.405
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
1.401
|
|
TTR
|
transthyretin
|
1.401
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
1.4
|
|
DARS2
|
aspartyl-tRNA synthetase 2, mitochondrial
|
1.4
|
|
PRLR
|
prolactin receptor
|
1.399
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
1.399
|
|
MMP3
|
matrix metallopeptidase 3
|
1.397
|
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
|
1.397
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
1.396
|
|
SELE
|
selectin E
|
1.395
|
|
CA4
|
carbonic anhydrase IV
|
1.394
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
1.394
|
|
CA8
|
carbonic anhydrase VIII
|
1.392
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
1.392
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
1.389
|
|
HTT
|
huntingtin
|
1.389
|
|
GC
|
group-specific component (vitamin D binding protein)
|
1.385
|
|
SLC35G6
|
solute carrier family 35, member G6
|
1.384
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.384
|
|
ADRB3
|
adrenoceptor beta 3
|
1.382
|
|
EGR1
|
early growth response 1
|
1.381
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
1.381
|
|
RHOA
|
ras homolog family member A
|
1.381
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
1.38
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
1.377
|
|
HPSE2
|
heparanase 2 (inactive)
|
1.374
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
1.373
|
|
CA3
|
carbonic anhydrase III
|
1.369
|
|
APOA1
|
apolipoprotein A-I
|
1.368
|
|
GHRH
|
growth hormone releasing hormone
|
1.368
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
1.368
|
|
GRIN2C
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
|
1.367
|
|
OC90
|
otoconin 90
|
1.367
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.367
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
1.366
|
|
PCDH19
|
protocadherin 19
|
1.365
|
|
TARDBP
|
TAR DNA binding protein
|
1.365
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
1.365
|
|
SLC1A6
|
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
|
1.364
|
|
PNLIP
|
pancreatic lipase
|
1.361
|
|
FGF5
|
fibroblast growth factor 5
|
1.361
|
|
NPPB
|
natriuretic peptide B
|
1.361
|
|
TAAR9
|
trace amine associated receptor 9 (gene/pseudogene)
|
1.36
|
|
SYT2
|
synaptotagmin II
|
1.359
|
|
TAAR8
|
trace amine associated receptor 8
|
1.357
|
|
CA14
|
carbonic anhydrase XIV
|
1.357
|
|
CMA1
|
chymase 1, mast cell
|
1.357
|
|
STX1B
|
syntaxin 1B
|
1.356
|
|
ELN
|
elastin
|
1.354
|
|
TCF4
|
transcription factor 4
|
1.354
|
|
FGA
|
fibrinogen alpha chain
|
1.353
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.353
|
|
TBP
|
TATA box binding protein
|
1.353
|
|
FGF4
|
fibroblast growth factor 4
|
1.352
|
|
SYN2
|
synapsin II
|
1.349
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
1.349
|
|
HTR3E
|
5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
|
1.349
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
1.348
|
|
POLG2
|
polymerase (DNA directed), gamma 2, accessory subunit
|
1.348
|
|
KCNK6
|
potassium channel, two pore domain subfamily K, member 6
|
1.347
|
|
NGFR
|
nerve growth factor receptor
|
1.347
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.346
|
|
RELN
|
reelin
|
1.344
|
|
PSEN2
|
presenilin 2
|
1.344
|
|
LBR
|
lamin B receptor
|
1.344
|
|
CALB1
|
calbindin 1, 28kDa
|
1.343
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
1.343
|
|
FGF9
|
fibroblast growth factor 9
|
1.341
|
|
P2RX6
|
purinergic receptor P2X, ligand gated ion channel, 6
|
1.339
|
|
HOMER1
|
homer scaffolding protein 1
|
1.339
|
|
ADCY1
|
adenylate cyclase 1 (brain)
|
1.337
|
|
TAAR6
|
trace amine associated receptor 6
|
1.337
|
|
MARVELD1
|
MARVEL domain containing 1
|
1.337
|
|
FGF3
|
fibroblast growth factor 3
|
1.337
|
|
ACVRL1
|
activin A receptor type II-like 1
|
1.336
|
|
PANX2
|
pannexin 2
|
1.336
|
|
PRKN
|
parkin RBR E3 ubiquitin protein ligase
|
1.336
|
|
NOTCH4
|
notch 4
|
1.335
|
|
SLC17A8
|
solute carrier family 17 (vesicular glutamate transporter), member 8
|
1.335
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.334
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
1.333
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
1.333
|
|
COL3A1
|
collagen, type III, alpha 1
|
1.333
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.332
|
|
PDSS1
|
prenyl (decaprenyl) diphosphate synthase, subunit 1
|
1.331
|
|
MME
|
membrane metallo-endopeptidase
|
1.331
|
|
PTEN
|
phosphatase and tensin homolog
|
1.331
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.331
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.331
|
|
ANO3
|
anoctamin 3
|
1.331
|
|
FGF20
|
fibroblast growth factor 20
|
1.33
|
|
DCLK3
|
doublecortin-like kinase 3
|
1.329
|
|
FGF16
|
fibroblast growth factor 16
|
1.329
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
1.329
|
|
FGF17
|
fibroblast growth factor 17
|
1.328
|
|
FGF7
|
fibroblast growth factor 7
|
1.328
|
|
SPINK2
|
serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)
|
1.328
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
1.328
|
|
FBN1
|
fibrillin 1
|
1.326
|
|
SLC1A7
|
solute carrier family 1 (glutamate transporter), member 7
|
1.326
|
|
FGF18
|
fibroblast growth factor 18
|
1.325
|
|
SCN4B
|
sodium channel, voltage gated, type IV beta subunit
|
1.325
|
|
COCH
|
cochlin
|
1.323
|
|
MC4R
|
melanocortin 4 receptor
|
1.323
|
|
CP
|
ceruloplasmin (ferroxidase)
|
1.323
|
|
TBC1D24
|
TBC1 domain family, member 24
|
1.323
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
1.322
|
|
USO1
|
USO1 vesicle transport factor
|
1.322
|
|
GCGR
|
glucagon receptor
|
1.321
|
|
CTSA
|
cathepsin A
|
1.321
|
|
NPPA
|
natriuretic peptide A
|
1.321
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
1.321
|
|
FGF22
|
fibroblast growth factor 22
|
1.321
|
|
GPSM2
|
G-protein signaling modulator 2
|
1.32
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
1.319
|
|
KIF26A
|
kinesin family member 26A
|
1.318
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.315
|
|
FGF10
|
fibroblast growth factor 10
|
1.314
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
1.314
|
|
XDH
|
xanthine dehydrogenase
|
1.314
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.314
|
|
GCH1
|
GTP cyclohydrolase 1
|
1.312
|
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10
|
1.312
|
|
NRXN2
|
neurexin 2
|
1.311
|
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta
|
1.31
|
|
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3
|
1.31
|
|
SLC38A4
|
solute carrier family 38, member 4
|
1.31
|
|
DEPDC5
|
DEP domain containing 5
|
1.31
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
1.31
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
1.308
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
1.307
|
|
GLA
|
galactosidase, alpha
|
1.307
|
|
LOX
|
lysyl oxidase
|
1.304
|
|
ETFDH
|
electron-transferring-flavoprotein dehydrogenase
|
1.303
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
1.302
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
1.302
|
|
NAXE
|
NAD(P)HX epimerase
|
1.302
|
|
GLRA1
|
glycine receptor, alpha 1
|
1.301
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
1.301
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
1.3
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
1.299
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
1.297
|
|
SCTR
|
secretin receptor
|
1.297
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
1.296
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
1.296
|
|
CADM1
|
cell adhesion molecule 1
|
1.296
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
1.295
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
1.294
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.293
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
1.293
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
1.293
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.292
|
|
P2RY4
|
pyrimidinergic receptor P2Y, G-protein coupled, 4
|
1.292
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1.291
|
|
MRS2
|
MRS2 magnesium transporter
|
1.291
|
|
CD68
|
CD68 molecule
|
1.29
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
1.289
|
|
ANXA5
|
annexin A5
|
1.289
|
|
CFDP1
|
craniofacial development protein 1
|
1.288
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.288
|
|
DAGLB
|
diacylglycerol lipase, beta
|
1.284
|
|
AHR
|
aryl hydrocarbon receptor
|
1.284
|
|
GPR18
|
G protein-coupled receptor 18
|
1.284
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
1.284
|
|
BTBD9
|
BTB (POZ) domain containing 9
|
1.284
|
|
ATXN3
|
ataxin 3
|
1.283
|
|
AGRP
|
agouti related neuropeptide
|
1.282
|
|
AANAT
|
aralkylamine N-acetyltransferase
|
1.282
|
|
NRP1
|
neuropilin 1
|
1.281
|
|
PRTN3
|
proteinase 3
|
1.28
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
1.28
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
1.28
|
|
H3-3B
|
H3.3 histone B
|
1.279
|
|
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10
|
1.278
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.278
|
|
KCNK7
|
potassium channel, two pore domain subfamily K, member 7
|
1.277
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
1.276
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
1.276
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.275
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
1.275
|
|
HDC
|
histidine decarboxylase
|
1.275
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
1.274
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.274
|
|
NPFF
|
neuropeptide FF-amide peptide precursor
|
1.272
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.271
|
|
DGKG
|
diacylglycerol kinase, gamma 90kDa
|
1.27
|
|
PON1
|
paraoxonase 1
|
1.27
|
|
SP9
|
Sp9 transcription factor
|
1.268
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.267
|
|
H3C12
|
H3 clustered histone 12
|
1.267
|
|
IFNA2
|
interferon, alpha 2
|
1.265
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
1.264
|
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2
|
1.264
|
|
JAG1
|
jagged 1
|
1.264
|
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1
|
1.262
|
|
ARHGAP28
|
Rho GTPase activating protein 28
|
1.262
|
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4
|
1.262
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.262
|
|
ENG
|
endoglin
|
1.26
|
|
HCN3
|
hyperpolarization activated cyclic nucleotide gated potassium channel 3
|
1.26
|
|
ECM1
|
extracellular matrix protein 1
|
1.259
|
|
CASR
|
calcium-sensing receptor
|
1.259
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
1.259
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
1.259
|
|
WSCD1
|
WSC domain containing 1
|
1.259
|
|
TREX1
|
three prime repair exonuclease 1
|
1.258
|
|
CCM2L
|
cerebral cavernous malformation 2-like
|
1.258
|
|
SYN3
|
synapsin III
|
1.256
|
|
MXRA8
|
matrix-remodelling associated 8
|
1.255
|
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18
|
1.255
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.255
|
|
COQ9
|
coenzyme Q9
|
1.255
|
|
CA12
|
carbonic anhydrase XII
|
1.255
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
1.255
|
|
H3-5
|
H3.5 histone
|
1.255
|
|
GSTM1
|
glutathione S-transferase mu 1
|
1.254
|
|
H3-4
|
H3.4 histone, cluster member
|
1.254
|
|
H3C13
|
H3 clustered histone 13
|
1.254
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.253
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
1.251
|
|
CA13
|
carbonic anhydrase XIII
|
1.251
|
|
C3
|
complement component 3
|
1.251
|
|
CBS
|
cystathionine-beta-synthase
|
1.251
|
|
ZNF555
|
zinc finger protein 555
|
1.249
|
|
ATXN2
|
ataxin 2
|
1.249
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
1.249
|
|
PYY
|
peptide YY
|
1.248
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
1.248
|
|
CD34
|
CD34 molecule
|
1.248
|
|
NPY5R
|
neuropeptide Y receptor Y5
|
1.248
|
|
KDR
|
kinase insert domain receptor
|
1.248
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
1.248
|
|
FUS
|
FUS RNA binding protein
|
1.247
|
|
FOXP3
|
forkhead box P3
|
1.247
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.246
|
|
UGT1A3
|
UDP glucuronosyltransferase 1 family, polypeptide A3
|
1.245
|
|
KCNS3
|
potassium voltage-gated channel, modifier subfamily S, member 3
|
1.244
|
|
SUCLG2
|
succinate-CoA ligase, GDP-forming, beta subunit
|
1.244
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
1.243
|
|
CD19
|
CD19 molecule
|
1.243
|
|
XPR1
|
xenotropic and polytropic retrovirus receptor 1
|
1.242
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
1.242
|
|
IL33
|
interleukin 33
|
1.241
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
1.24
|
|
HDAC4
|
histone deacetylase 4
|
1.239
|
|
DGUOK
|
deoxyguanosine kinase
|
1.239
|
|
IL3
|
interleukin 3
|
1.238
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.238
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.238
|
|
CNTNAP1
|
contactin associated protein 1
|
1.235
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
1.235
|
|
TRIM8
|
tripartite motif containing 8
|
1.234
|
|
ABAT
|
4-aminobutyrate aminotransferase
|
1.233
|
|
NXN
|
nucleoredoxin
|
1.233
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
1.232
|
|
RETNLB
|
resistin like beta
|
1.232
|
|
PRNP
|
prion protein
|
1.232
|
|
KCND1
|
potassium channel, voltage gated Shal related subfamily D, member 1
|
1.232
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
1.231
|
|
CA5B
|
carbonic anhydrase VB, mitochondrial
|
1.23
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
1.23
|
|
CLU
|
clusterin
|
1.23
|
|
SLC4A8
|
solute carrier family 4, sodium bicarbonate cotransporter, member 8
|
1.228
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.227
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.227
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
1.226
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
1.226
|
|
KITLG
|
KIT ligand
|
1.226
|
|
HDAC2
|
histone deacetylase 2
|
1.225
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.223
|
|
CA6
|
carbonic anhydrase VI
|
1.223
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
1.222
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
1.221
|
|
TLR3
|
toll-like receptor 3
|
1.221
|
|
RETN
|
resistin
|
1.22
|
|
GPR119
|
G protein-coupled receptor 119
|
1.219
|
|
ATN1
|
atrophin 1
|
1.219
|
|
KCNG2
|
potassium channel, voltage gated modifier subfamily G, member 2
|
1.219
|
|
CCM2
|
cerebral cavernous malformation 2
|
1.218
|
|
BMP8A
|
bone morphogenetic protein 8a
|
1.218
|
|
FKBP5
|
FK506 binding protein 5
|
1.218
|
|
TPRA1
|
transmembrane protein, adipocyte asscociated 1
|
1.218
|
|
PER3
|
period circadian clock 3
|
1.217
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.217
|
|
SLC9B1
|
solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1
|
1.215
|
|
SUCLA2
|
succinate-CoA ligase, ADP-forming, beta subunit
|
1.215
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
1.215
|
|
IGSF9B
|
immunoglobulin superfamily, member 9B
|
1.213
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
1.212
|
|
PF4V1
|
platelet factor 4 variant 1
|
1.212
|
|
CHRM4
|
cholinergic receptor, muscarinic 4
|
1.21
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
1.21
|
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2
|
1.21
|
|
PINK1
|
PTEN induced putative kinase 1
|
1.209
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
1.209
|
|
ATXN7L3B
|
ataxin 7-like 3B
|
1.209
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
1.208
|
|
PTH2R
|
parathyroid hormone 2 receptor
|
1.207
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
1.207
|
|
PITX2
|
paired-like homeodomain 2
|
1.207
|
|
CA7
|
carbonic anhydrase VII
|
1.207
|
|
TGM6
|
transglutaminase 6
|
1.206
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
1.206
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
1.205
|
|
NEFH
|
neurofilament, heavy polypeptide
|
1.204
|
|
LTF
|
lactotransferrin
|
1.204
|
|
PDSS2
|
prenyl (decaprenyl) diphosphate synthase, subunit 2
|
1.203
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
1.203
|
|
CARTPT
|
CART prepropeptide
|
1.203
|
|
GAST
|
gastrin
|
1.203
|
|
MB
|
myoglobin
|
1.201
|
|
CNTF
|
ciliary neurotrophic factor
|
1.2
|
|
GNB5
|
guanine nucleotide binding protein (G protein), beta 5
|
1.2
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
1.2
|
|
AVIL
|
advillin
|
1.199
|
|
MMP1
|
matrix metallopeptidase 1
|
1.198
|
|
KCNJ9
|
potassium channel, inwardly rectifying subfamily J, member 9
|
1.198
|
|
NALCN
|
sodium leak channel, non selective
|
1.197
|
|
TLR7
|
toll-like receptor 7
|
1.197
|
|
DMD
|
dystrophin
|
1.196
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
1.195
|
|
TBC1D7
|
TBC1 domain family, member 7
|
1.195
|
|
MLX
|
MLX, MAX dimerization protein
|
1.195
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
1.194
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.193
|
|
GPR139
|
G protein-coupled receptor 139
|
1.193
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
1.192
|
|
HDAC3
|
histone deacetylase 3
|
1.19
|
|
GPR26
|
G protein-coupled receptor 26
|
1.19
|
|
MAX
|
MYC associated factor X
|
1.19
|
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
1.189
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
1.188
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
1.187
|
|
TMEM100
|
transmembrane protein 100
|
1.187
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
1.187
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
1.186
|
|
PPAN-P2RY11
|
PPAN-P2RY11 readthrough
|
1.186
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
1.184
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.182
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.182
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
1.182
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.18
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.178
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
1.178
|
|
GPR149
|
G protein-coupled receptor 149
|
1.177
|
|
FSHR
|
follicle stimulating hormone receptor
|
1.177
|
|
BDKRB2
|
bradykinin receptor B2
|
1.177
|
|
CCND1
|
cyclin D1
|
1.175
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
1.175
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.173
|
|
MEIS1
|
Meis homeobox 1
|
1.171
|
|
SI
|
sucrase-isomaltase (alpha-glucosidase)
|
1.171
|
|
KCNC2
|
potassium channel, voltage gated Shaw related subfamily C, member 2
|
1.171
|
|
ANXA2
|
annexin A2
|
1.171
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
1.169
|
|
REM2
|
RAS (RAD and GEM)-like GTP binding 2
|
1.169
|
|
DTNA
|
dystrobrevin, alpha
|
1.169
|
|
TPO
|
thyroid peroxidase
|
1.168
|
|
COL5A1
|
collagen, type V, alpha 1
|
1.167
|
|
HTR3C
|
5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
|
1.166
|
|
NOX1
|
NADPH oxidase 1
|
1.165
|
|
SP6
|
Sp6 transcription factor
|
1.165
|
|
PARK7
|
parkinson protein 7
|
1.165
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
1.164
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
1.164
|
|
SLC41A2
|
solute carrier family 41 (magnesium transporter), member 2
|
1.164
|
|
ADORA3
|
adenosine A3 receptor
|
1.163
|
|
STIM1
|
stromal interaction molecule 1
|
1.162
|
|
THY1
|
Thy-1 cell surface antigen
|
1.162
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
1.162
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
1.162
|
|
IL9
|
interleukin 9
|
1.162
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.161
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
1.16
|
|
CST3
|
cystatin C
|
1.16
|
|
TYR
|
tyrosinase
|
1.159
|
|
FOXC1
|
forkhead box C1
|
1.158
|
|
SUCLG1
|
succinate-CoA ligase, alpha subunit
|
1.158
|
|
TXN
|
thioredoxin
|
1.157
|
|
TFRC
|
transferrin receptor
|
1.157
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
1.157
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.157
|
|
CTSS
|
cathepsin S
|
1.156
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
1.156
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
1.156
|
|
CCKAR
|
cholecystokinin A receptor
|
1.155
|
|
ENTPD8
|
ectonucleoside triphosphate diphosphohydrolase 8
|
1.154
|
|
IFNA17
|
interferon, alpha 17
|
1.154
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
1.153
|
|
SCN3B
|
sodium channel, voltage gated, type III beta subunit
|
1.153
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
1.153
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
1.153
|
|
CD40LG
|
CD40 ligand
|
1.153
|
|
HTR3D
|
5-hydroxytryptamine (serotonin) receptor 3D, ionotropic
|
1.153
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
1.152
|
|
ADK
|
adenosine kinase
|
1.152
|
|
IFNA7
|
interferon, alpha 7
|
1.152
|
|
IFNA16
|
interferon, alpha 16
|
1.152
|
|
IFNA21
|
interferon, alpha 21
|
1.151
|
|
IFNA6
|
interferon, alpha 6
|
1.151
|
|
IFNA8
|
interferon, alpha 8
|
1.151
|
|
IFNA10
|
interferon, alpha 10
|
1.151
|
|
IFNA14
|
interferon, alpha 14
|
1.151
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
1.151
|
|
TSPAN16
|
tetraspanin 16
|
1.15
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
1.15
|
|
IFNA5
|
interferon, alpha 5
|
1.15
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
1.15
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
1.149
|
|
UNC13B
|
unc-13 homolog B (C. elegans)
|
1.148
|
|
NKRF
|
NFKB repressing factor
|
1.148
|
|
IFNA13
|
interferon, alpha 13
|
1.148
|
|
CHGA
|
chromogranin A
|
1.146
|
|
BMP8B
|
bone morphogenetic protein 8b
|
1.146
|
|
IFNA4
|
interferon, alpha 4
|
1.146
|
|
CLDN1
|
claudin 1
|
1.144
|
|
ZFHX3
|
zinc finger homeobox 3
|
1.143
|
|
COL5A2
|
collagen, type V, alpha 2
|
1.143
|
|
PPY
|
pancreatic polypeptide
|
1.143
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.143
|
|
SV2B
|
synaptic vesicle glycoprotein 2B
|
1.142
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
1.142
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
1.141
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
1.141
|
|
LAP3
|
leucine aminopeptidase 3
|
1.141
|
|
GRP
|
gastrin-releasing peptide
|
1.14
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
1.14
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
1.139
|
|
GDF15
|
growth differentiation factor 15
|
1.139
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
1.137
|
|
MFN2
|
mitofusin 2
|
1.137
|
|
BCL2L1
|
BCL2-like 1
|
1.136
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
1.136
|
|
TSC2
|
tuberous sclerosis 2
|
1.136
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
1.136
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
1.135
|
|
IL22
|
interleukin 22
|
1.134
|
|
TBL2
|
transducin (beta)-like 2
|
1.134
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
1.133
|
|
KYAT1
|
kynurenine aminotransferase 1
|
1.132
|
|
SPP1
|
secreted phosphoprotein 1
|
1.131
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
1.131
|
|
ADA
|
adenosine deaminase
|
1.13
|
|
NMUR2
|
neuromedin U receptor 2
|
1.128
|
|
MAP2
|
microtubule-associated protein 2
|
1.127
|
|
PCDH10
|
protocadherin 10
|
1.126
|
|
CACNB1
|
calcium channel, voltage-dependent, beta 1 subunit
|
1.126
|
|
KCNV1
|
potassium channel, voltage gated modifier subfamily V, member 1
|
1.125
|
|
LDLR
|
low density lipoprotein receptor
|
1.125
|
|
AMH
|
anti-Mullerian hormone
|
1.123
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.123
|
|
DCX
|
doublecortin
|
1.122
|
|
PDPN
|
podoplanin
|
1.122
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
1.122
|
|
APTX
|
aprataxin
|
1.122
|
|
MLN
|
motilin
|
1.122
|
|
MGAM
|
maltase-glucoamylase
|
1.122
|
|
NLGN3
|
neuroligin 3
|
1.121
|
|
PAX6
|
paired box 6
|
1.121
|
|
BIN1
|
bridging integrator 1
|
1.12
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.12
|
|
PNMA2
|
paraneoplastic Ma antigen 2
|
1.12
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.117
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
1.116
|
|
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4
|
1.116
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
1.116
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
1.114
|
|
NPAS4
|
neuronal PAS domain protein 4
|
1.114
|
|
SURF1
|
surfeit 1
|
1.114
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.113
|
|
CLDN7
|
claudin 7
|
1.112
|
|
NOTCH1
|
notch 1
|
1.111
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
1.111
|
|
GH1
|
growth hormone 1
|
1.111
|
|
IL31
|
interleukin 31
|
1.111
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.111
|
|
MRGPRX1
|
MAS-related GPR, member X1
|
1.11
|
|
LEPR
|
leptin receptor
|
1.11
|
|
ATXN10
|
ataxin 10
|
1.109
|
|
LRRC8A
|
leucine rich repeat containing 8 family, member A
|
1.109
|
|
BTBD16
|
BTB (POZ) domain containing 16
|
1.108
|
|
NMU
|
neuromedin U
|
1.108
|
|
AR
|
androgen receptor
|
1.108
|
|
BTBD7
|
BTB (POZ) domain containing 7
|
1.108
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
1.107
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
1.105
|
|
MEFV
|
Mediterranean fever
|
1.104
|
|
CALB2
|
calbindin 2
|
1.104
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
1.104
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
1.103
|
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1
|
1.103
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
1.102
|
|
NPTX2
|
neuronal pentraxin II
|
1.102
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.102
|
|
TG
|
thyroglobulin
|
1.101
|
|
RAD51B
|
RAD51 paralog B
|
1.101
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.101
|
|
UTS2
|
urotensin 2
|
1.101
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
1.1
|
|
B3GAT2
|
beta-1,3-glucuronyltransferase 2
|
1.099
|
|
THBD
|
thrombomodulin
|
1.099
|
|
FGG
|
fibrinogen gamma chain
|
1.098
|
|
FXN
|
frataxin
|
1.098
|
|
PRKCA
|
protein kinase C, alpha
|
1.098
|
|
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3
|
1.097
|
|
ECE1
|
endothelin converting enzyme 1
|
1.097
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.097
|
|
HDAC6
|
histone deacetylase 6
|
1.096
|
|
RNF214
|
ring finger protein 214
|
1.096
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
1.095
|
|
MPV17
|
MpV17 mitochondrial inner membrane protein
|
1.094
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
1.093
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.093
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
1.093
|
|
ICA1L
|
islet cell autoantigen 1,69kDa-like
|
1.092
|
|
VGF
|
VGF nerve growth factor inducible
|
1.091
|
|
RORA
|
RAR-related orphan receptor A
|
1.091
|
|
C1S
|
complement component 1, s subcomponent
|
1.091
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.091
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.091
|
|
PANX3
|
pannexin 3
|
1.09
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
1.089
|
|
RTN4R
|
reticulon 4 receptor
|
1.089
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.087
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
1.087
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
1.086
|
|
FPR1
|
formyl peptide receptor 1
|
1.086
|
|
RBM8A
|
RNA binding motif protein 8A
|
1.085
|
|
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)
|
1.085
|
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4
|
1.085
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
1.083
|
|
IL7
|
interleukin 7
|
1.082
|
|
CNGA2
|
cyclic nucleotide gated channel alpha 2
|
1.082
|
|
EDN3
|
endothelin 3
|
1.081
|
|
HAAO
|
3-hydroxyanthranilate 3,4-dioxygenase
|
1.081
|
|
OXR1
|
oxidation resistance 1
|
1.081
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
1.081
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
1.08
|
|
TLR9
|
toll-like receptor 9
|
1.08
|
|
TRIM21
|
tripartite motif containing 21
|
1.079
|
|
MYO7A
|
myosin VIIA
|
1.079
|
|
CS
|
citrate synthase
|
1.078
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
1.077
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
1.076
|
|
DNM1L
|
dynamin 1-like
|
1.076
|
|
NNMT
|
nicotinamide N-methyltransferase
|
1.075
|
|
GALR1
|
galanin receptor 1
|
1.075
|
|
TOX3
|
TOX high mobility group box family member 3
|
1.075
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
1.074
|
|
COQ6
|
coenzyme Q6 monooxygenase
|
1.074
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
1.073
|
|
ANO10
|
anoctamin 10
|
1.073
|
|
TNXB
|
tenascin XB
|
1.073
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
1.072
|
|
SP1
|
Sp1 transcription factor
|
1.072
|
|
CCN2
|
cellular communication network factor 2
|
1.072
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
1.071
|
|
PLP1
|
proteolipid protein 1
|
1.071
|
|
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1
|
1.07
|
|
GIP
|
gastric inhibitory polypeptide
|
1.07
|
|
GRK2
|
G protein-coupled receptor kinase 2
|
1.07
|
|
ABHD6
|
abhydrolase domain containing 6
|
1.068
|
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
1.068
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
1.067
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.067
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
1.067
|
|
SHH
|
sonic hedgehog
|
1.067
|
|
NLGN1
|
neuroligin 1
|
1.066
|
|
ARG1
|
arginase 1
|
1.066
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.066
|
|
AMY2A
|
amylase, alpha 2A (pancreatic)
|
1.066
|
|
NOP53
|
NOP53 ribosome biogenesis factor
|
1.066
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
1.065
|
|
TLR10
|
toll-like receptor 10
|
1.065
|
|
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
|
1.064
|
|
SQSTM1
|
sequestosome 1
|
1.064
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
1.064
|
|
EGR2
|
early growth response 2
|
1.063
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
1.063
|
|
GAP43
|
growth associated protein 43
|
1.063
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
1.063
|
|
SUGP1
|
SURP and G patch domain containing 1
|
1.062
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
1.061
|
|
NBEA
|
neurobeachin
|
1.061
|
|
SMAD3
|
SMAD family member 3
|
1.06
|
|
ATM
|
ATM serine/threonine kinase
|
1.06
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
1.06
|
|
ELFN1
|
extracellular leucine-rich repeat and fibronectin type III domain containing 1
|
1.06
|
|
CD86
|
CD86 molecule
|
1.059
|
|
ANGPT1
|
angiopoietin 1
|
1.059
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
1.058
|
|
TTBK2
|
tau tubulin kinase 2
|
1.058
|
|
VTN
|
vitronectin
|
1.058
|
|
PRKCE
|
protein kinase C, epsilon
|
1.058
|
|
NLGN4X
|
neuroligin 4, X-linked
|
1.057
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
1.056
|
|
TGFB2
|
transforming growth factor, beta 2
|
1.056
|
|
NLGN2
|
neuroligin 2
|
1.055
|
|
MCOLN1
|
mucolipin 1
|
1.055
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
1.055
|
|
ANO2
|
anoctamin 2, calcium activated chloride channel
|
1.055
|
|
OR2AG1
|
olfactory receptor, family 2, subfamily AG, member 1 (gene/pseudogene)
|
1.054
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
1.05
|
|
SMAD9
|
SMAD family member 9
|
1.05
|
|
TUBB4A
|
tubulin, beta 4A class IVa
|
1.05
|
|
ITK
|
IL2-inducible T-cell kinase
|
1.05
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
1.049
|
|
UGT2A2
|
UDP glucuronosyltransferase 2 family, polypeptide A2
|
1.049
|
|
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28
|
1.049
|
|
IL15
|
interleukin 15
|
1.048
|
|
AMPH
|
amphiphysin
|
1.048
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
1.047
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
1.047
|
|
SGCE
|
sarcoglycan, epsilon
|
1.047
|
|
GPR37L1
|
G protein-coupled receptor 37 like 1
|
1.047
|
|
C3ORF38
|
chromosome 3 open reading frame 38
|
1.047
|
|
PGF
|
placental growth factor
|
1.046
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
1.045
|
|
ORM1
|
orosomucoid 1
|
1.045
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
1.045
|
|
NRTN
|
neurturin
|
1.045
|
|
SEMA3D
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
|
1.044
|
|
OXCT1
|
3-oxoacid CoA transferase 1
|
1.043
|
|
H2AC18
|
H2A clustered histone 18
|
1.043
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
1.042
|
|
GLB1
|
galactosidase, beta 1
|
1.041
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
1.04
|
|
IL6R
|
interleukin 6 receptor
|
1.04
|
|
NAGS
|
N-acetylglutamate synthase
|
1.04
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
1.04
|
|
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9
|
1.039
|
|
SLC4A5
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 5
|
1.039
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
1.039
|
|
GH2
|
growth hormone 2
|
1.039
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
1.039
|
|
KCNJ16
|
potassium channel, inwardly rectifying subfamily J, member 16
|
1.038
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
1.038
|
|
PICK1
|
protein interacting with PRKCA 1
|
1.036
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
1.036
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
1.036
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
1.035
|
|
CTSV
|
cathepsin V
|
1.035
|
|
UGT2B11
|
UDP glucuronosyltransferase 2 family, polypeptide B11
|
1.035
|
|
NPS
|
neuropeptide S
|
1.035
|
|
MED14
|
mediator complex subunit 14
|
1.035
|
|
LHB
|
luteinizing hormone beta polypeptide
|
1.034
|
|
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A5
|
1.033
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
1.033
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
1.032
|
|
MFSD2A
|
major facilitator superfamily domain containing 2A
|
1.031
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
1.03
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
1.03
|
|
GRM8
|
glutamate receptor, metabotropic 8
|
1.029
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
1.028
|
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
1.027
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.026
|
|
PYGL
|
phosphorylase, glycogen, liver
|
1.026
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
1.026
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
1.025
|
|
POLI
|
polymerase (DNA directed) iota
|
1.025
|
|
KCNAB1
|
potassium channel, voltage gated subfamily A regulatory beta subunit 1
|
1.025
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
1.024
|
|
NAAA
|
N-acylethanolamine acid amidase
|
1.023
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
1.023
|
|
H2AC20
|
H2A clustered histone 20
|
1.023
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.022
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
1.021
|
|
KCNF1
|
potassium channel, voltage gated modifier subfamily F, member 1
|
1.021
|
|
DOCK6
|
dedicator of cytokinesis 6
|
1.021
|
|
TMEM91
|
transmembrane protein 91
|
1.021
|
|
CD38
|
CD38 molecule
|
1.02
|
|
ZNF462
|
zinc finger protein 462
|
1.02
|
|
CD163
|
CD163 molecule
|
1.02
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
1.02
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
1.019
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
1.019
|
|
PYGB
|
phosphorylase, glycogen; brain
|
1.018
|
|
PDCD10
|
programmed cell death 10
|
1.017
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
1.017
|
|
CORT
|
cortistatin
|
1.017
|
|
AGTR2
|
angiotensin II receptor, type 2
|
1.017
|
|
ACO2
|
aconitase 2, mitochondrial
|
1.016
|
|
TUBB3
|
tubulin, beta 3 class III
|
1.015
|
|
KCNK15
|
potassium channel, two pore domain subfamily K, member 15
|
1.014
|
|
PYGM
|
phosphorylase, glycogen, muscle
|
1.012
|
|
DUSP1
|
dual specificity phosphatase 1
|
1.012
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
1.011
|
|
TYMP
|
thymidine phosphorylase
|
1.011
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
1.011
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
1.011
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
1.01
|
|
BTNL2
|
butyrophilin-like 2
|
1.009
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
1.009
|
|
UGT2A3
|
UDP glucuronosyltransferase 2 family, polypeptide A3
|
1.009
|
|
CYREN
|
cell cycle regulator of NHEJ
|
1.009
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
1.008
|
|
HDAC11
|
histone deacetylase 11
|
1.008
|
|
NINJ2
|
ninjurin 2
|
1.008
|
|
STH
|
saitohin
|
1.007
|
|
SP3
|
Sp3 transcription factor
|
1.006
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
1.005
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
1.004
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.003
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
1.003
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
1.003
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
1.003
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
1.003
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
1.002
|
|
MYT1L
|
myelin transcription factor 1-like
|
1.002
|
|
SPAST
|
spastin
|
1.001
|
|
MRPS21
|
mitochondrial ribosomal protein S21
|
1.001
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
1.001
|
|
KYAT3
|
kynurenine aminotransferase 3
|
1.0
|
